The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
Theradaptive, a Maryland-based, privately held, clinical-stage biologics company, today announced the initiation of patient dosing in Maryland for the ongoing OASIS Phase I/II clinical trial assessing ...
The University of California, Davis (UC Davis) veterinary hospital recently announced the establishment of a Neurosurgery ...
Attending the Mahakumbh Mela demands extensive walking and standing, resulting in potential bone and joint pains. Essential ...